Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ad26.ZEBOV/MVA-BN-Filo Ebola Vaccine in Healthcare Workers
NCT04028349Phase 2Completed
- Sponsor
- MRC/UVRI and LSHTM Uganda Research Unit
- Start
- Aug 2019
- Primary completion
- Mar 2021
- Modality
- Viral Vector Vaccines, DNA Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of zabdeno, Mvabea in Ebola virus disease (EVD), sponsored by MRC/UVRI and LSHTM Uganda Research Unit. Started Aug 2019; status: completed.
02
Drugs
zabdenoMvabea
03
Conditions
Ebola virus disease (EVD)
Beyond the preview
Go deeper on NCT04028349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04028349.